Ticker
DERMCompany Name
JOURNEY MEDICAL CORPSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 81.16M | $ 20.29M | 25% |
3/31/2025 | $ 84.96M | $ 21.07M | 24.8% |
12/31/2024 | $ 80.24M | $ 20.3M | 25.31% |
9/30/2024 | $ 64.04M | $ 22.46M | 35.07% |
6/30/2024 | $ 65.19M | $ 23.91M | 36.68% |
3/31/2024 | $ 66.57M | $ 24.06M | 36.14% |
12/31/2023 | $ 76.85M | $ 27.44M | 35.71% |
9/30/2023 | $ 65.92M | $ 24.75M | 37.55% |
6/30/2023 | $ 69.75M | $ 16.98M | 24.35% |
3/31/2023 | $ 95.85M | $ 26.1M | 27.23% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for JOURNEY MEDICAL CORP is calculated as follows: CashnEq [ $ 8.25M ] / Assets [ $ 51.91M ]
(=) Cash to Assets [ 15.89% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |